SE9603669D0 - New combination - Google Patents

New combination

Info

Publication number
SE9603669D0
SE9603669D0 SE9603669A SE9603669A SE9603669D0 SE 9603669 D0 SE9603669 D0 SE 9603669D0 SE 9603669 A SE9603669 A SE 9603669A SE 9603669 A SE9603669 A SE 9603669A SE 9603669 D0 SE9603669 D0 SE 9603669D0
Authority
SE
Sweden
Prior art keywords
active ingredient
new combination
kit
composition
salt
Prior art date
Application number
SE9603669A
Other languages
Swedish (sv)
Inventor
Jan Trofast
Anders Ullman
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Priority to SE9603669A priority Critical patent/SE9603669D0/en
Publication of SE9603669D0 publication Critical patent/SE9603669D0/en
Priority to CA002239308A priority patent/CA2239308A1/en
Priority to CZ981761A priority patent/CZ176198A3/en
Priority to BR9706822A priority patent/BR9706822A/en
Priority to EP97944242A priority patent/EP0871450A1/en
Priority to AU45782/97A priority patent/AU715319B2/en
Priority to PCT/SE1997/001606 priority patent/WO1998015280A1/en
Priority to PL97327037A priority patent/PL327037A1/en
Priority to KR1019980704266A priority patent/KR19990071975A/en
Priority to NZ330482A priority patent/NZ330482A/en
Priority to SK751-98A priority patent/SK75198A3/en
Priority to HU9901674A priority patent/HUP9901674A3/en
Priority to JP10517442A priority patent/JP2000502365A/en
Priority to TW086114371A priority patent/TW470647B/en
Priority to ZA9708889A priority patent/ZA978889B/en
Priority to ARP970104615A priority patent/AR013614A1/en
Priority to MYPI97004698A priority patent/MY128337A/en
Priority to NO982414A priority patent/NO982414L/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The invention provides a composition or kit having as a first active ingredient formoterol, or a salt or solvate derivative thereof, and having as a second active ingredient budesonide, wherein the molar ratio of the first active ingredient to the second active ingredient is from 1:30 to 1:36, and the use of the composition and kit in the treatment of respiratory disorders.
SE9603669A 1996-10-08 1996-10-08 New combination SE9603669D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
SE9603669A SE9603669D0 (en) 1996-10-08 1996-10-08 New combination
JP10517442A JP2000502365A (en) 1996-10-08 1997-09-24 New combinations
KR1019980704266A KR19990071975A (en) 1996-10-08 1997-09-24 New complex composition
SK751-98A SK75198A3 (en) 1996-10-08 1997-09-24 Pharmaceutical composition
BR9706822A BR9706822A (en) 1996-10-08 1997-09-24 Process kit composition for treatment of a respiratory disorder and use of the formoterol kit composition of a pharmaceutically acceptable salt or solvate of it and budesonide
EP97944242A EP0871450A1 (en) 1996-10-08 1997-09-24 New combination
AU45782/97A AU715319B2 (en) 1996-10-08 1997-09-24 New combination
PCT/SE1997/001606 WO1998015280A1 (en) 1996-10-08 1997-09-24 New combination
PL97327037A PL327037A1 (en) 1996-10-08 1997-09-24 Novel combination
CA002239308A CA2239308A1 (en) 1996-10-08 1997-09-24 New combination
NZ330482A NZ330482A (en) 1996-10-08 1997-09-24 Compositions comprising formoterol and budesonide for treating respiratory disorders
CZ981761A CZ176198A3 (en) 1996-10-08 1997-09-24 Novel preparation
HU9901674A HUP9901674A3 (en) 1996-10-08 1997-09-24 New pharmaceutical combination
TW086114371A TW470647B (en) 1996-10-08 1997-10-02 Composition and pharmaceutical combination kit comprising formoterol and budesonide
ZA9708889A ZA978889B (en) 1996-10-08 1997-10-03 New combination of steroids.
ARP970104615A AR013614A1 (en) 1996-10-08 1997-10-07 NEW COMPOSITION THAT INCLUDES A COMBINATION OF STEROIDS, A KIT THAT CONTAINS IT, THE USE OF THE SAME, THE USE OF SUCH KIT OF FORMOTEROL AND DEBUDESONIDA IN THE MANUFACTURE OF A MEDICINAL PRODUCT
MYPI97004698A MY128337A (en) 1996-10-08 1997-10-07 New combination of steroids
NO982414A NO982414L (en) 1996-10-08 1998-05-27 New combination

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9603669A SE9603669D0 (en) 1996-10-08 1996-10-08 New combination

Publications (1)

Publication Number Publication Date
SE9603669D0 true SE9603669D0 (en) 1996-10-08

Family

ID=20404167

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9603669A SE9603669D0 (en) 1996-10-08 1996-10-08 New combination

Country Status (18)

Country Link
EP (1) EP0871450A1 (en)
JP (1) JP2000502365A (en)
KR (1) KR19990071975A (en)
AR (1) AR013614A1 (en)
AU (1) AU715319B2 (en)
BR (1) BR9706822A (en)
CA (1) CA2239308A1 (en)
CZ (1) CZ176198A3 (en)
HU (1) HUP9901674A3 (en)
MY (1) MY128337A (en)
NO (1) NO982414L (en)
NZ (1) NZ330482A (en)
PL (1) PL327037A1 (en)
SE (1) SE9603669D0 (en)
SK (1) SK75198A3 (en)
TW (1) TW470647B (en)
WO (1) WO1998015280A1 (en)
ZA (1) ZA978889B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5983956A (en) * 1994-10-03 1999-11-16 Astra Aktiebolag Formulation for inhalation
SE9700136D0 (en) * 1997-01-20 1997-01-20 Astra Ab New formulation
US5980949A (en) * 1994-10-03 1999-11-09 Astra Aktiebolag Formulation for inhalation
SE9700134D0 (en) * 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700135D0 (en) 1997-01-20 1997-01-20 Astra Ab New formulation
SE9700133D0 (en) * 1997-01-20 1997-01-20 Astra Ab New formulation
ID24063A (en) * 1997-06-27 2000-07-06 Astra Ab ANTI ASMA MEDICINE COMBINATIONS
SE9703407D0 (en) 1997-09-19 1997-09-19 Astra Ab New use
SE9802073D0 (en) 1998-06-11 1998-06-11 Astra Ab New use
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
SE9900834D0 (en) * 1999-03-09 1999-03-09 Astra Ab Novel combination
DE19921693A1 (en) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
GB0009584D0 (en) * 2000-04-18 2000-06-07 Glaxo Group Ltd Pharmaceutical compositions
GB0012260D0 (en) 2000-05-19 2000-07-12 Astrazeneca Ab Novel composition
FI20002216A0 (en) 2000-10-06 2000-10-06 Orion Yhtymae Oyj Combination particles for asthma therapy
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
SE0200312D0 (en) 2002-02-01 2002-02-01 Astrazeneca Ab Novel composition
SE527069C2 (en) 2003-06-19 2005-12-13 Mederio Ag Method and apparatus for administering drug powder
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
US20050026887A1 (en) * 2003-07-29 2005-02-03 Boehringer Ingelheim International Gmbh Medicaments for inhalation comprising an anticholinergic and a steroid
DK2054042T3 (en) 2006-06-30 2020-08-03 Iceutica Pty Ltd Processes for the preparation of biologically active compounds in nanoparticle form
MX2009008794A (en) 2007-02-19 2009-08-25 Cipla Ltd Pharmaceutical combinations.
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
CN107412212B (en) 2009-05-29 2021-01-22 珍珠治疗公司 Pulmonary delivery of long-acting muscarinic antagonists and long-acting beta2Compositions of adrenergic receptor agonists and related methods and systems
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
HUE055562T2 (en) 2011-11-23 2021-11-29 Therapeuticsmd Inc Natural combination hormone replacement formulations and therapies
CN107875127A (en) * 2012-02-28 2018-04-06 艾塞尤提卡控股公司 Inhalable drug composition
ITMI20130571A1 (en) 2013-04-10 2014-10-11 Zambon Spa PHARMACEUTICAL COMPOSITION CONTAINING BUDESONIDE AND FORMOTEROL

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU673660C (en) * 1991-12-18 2002-07-25 Astrazeneca Ab New combination of formoterol and budesonide

Also Published As

Publication number Publication date
HUP9901674A2 (en) 1999-09-28
CA2239308A1 (en) 1998-04-16
TW470647B (en) 2002-01-01
SK75198A3 (en) 1998-11-04
AU4578297A (en) 1998-05-05
PL327037A1 (en) 1998-11-09
NO982414D0 (en) 1998-05-27
WO1998015280A1 (en) 1998-04-16
MY128337A (en) 2007-01-31
BR9706822A (en) 1999-03-23
NO982414L (en) 1998-05-27
NZ330482A (en) 1999-11-29
CZ176198A3 (en) 1998-09-16
AU715319B2 (en) 2000-01-20
AR013614A1 (en) 2001-01-10
JP2000502365A (en) 2000-02-29
HUP9901674A3 (en) 2001-04-28
EP0871450A1 (en) 1998-10-21
KR19990071975A (en) 1999-09-27
ZA978889B (en) 1998-04-08

Similar Documents

Publication Publication Date Title
SE9603669D0 (en) New combination
ATE390133T1 (en) GABAPENTINE ANALOGUES FOR SLEEP DISORDERS
ES2182357T3 (en) NEW USE OF BUDESONIDE AND FORMOTEROL.
DE69721766D1 (en) NEW MEDICAL FORMULATION
WO2002036562A3 (en) 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
CA2259621A1 (en) Isocoumarin derivatives and their use in medicines
CA2222676A1 (en) New pharmaceutical composition with anaesthetic effect
BR9711194A (en) Use of chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease.
CY1108610T1 (en) IL-2 Peptides and their derivatives and their use as therapeutic agents
WO2003053359A3 (en) 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders
GB0005251D0 (en) Therapeutic compounds
EE05661B1 (en) Use of a Formoterol and Budesonide Composition for the Prevention or Treatment of Asthma-Related Conditions
CA2199844A1 (en) Compositions for the treatment of skin disorders
SE9704644D0 (en) New use
ATE226084T1 (en) WOUND HEALING AND TREATMENT OF FIBROSIS
MD502G2 (en) New adenozine derivatives, methods of obtainitg thereof, farmaceutical compositions on the base thereof
HUP9902415A2 (en) Solid instant-release forms of administration and process for producing the same
BG102667A (en) Diosgenine-containing composition
ATE201680T1 (en) 2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE ACID ADDITION SALTS
BR9808299A (en) The use of levobupivacaìna or ropivacaìna for the treatment of migraine
EP0373771A3 (en) New pharmaceutical uses for cystatins
TWI262791B (en) 6-methoxy-2-naphthylacetic acid prodrugs
ID26132A (en) MAKING FOR TREATMENT OF ERROR FUNCTION INTERFERENCE
DE59705183D1 (en) THERAPEUTIC AGENTS, CONTAINING LEAVES AGAINST ASTHMA
WO2000002877A3 (en) New pharmaceutically active compounds